At this time, I would like to welcome everyone to the SkyWest, Inc. Fourth Quarter and Full Year 2024 Results Call. All lines have been placed on mute to prevent any background noise. After the ...
Novartis was among the most prolific pharma dealmakers in 2024, a trend that it expects to continue with more bolt-on deals this year to set up for sustainable long-term growth.